Cargando…
Corrigendum: Activation of A2A receptor by PDRN reduces neuronal damage and stimulates WNT/β-catenin driven neurogenesis in spinal cord injury
Autores principales: | Irrera, Natasha, Arcoraci, Vincenzo, Mannino, Federica, Vermiglio, Giovanna, Pallio, Giovanni, Minutoli, Letteria, Bagnato, Gianluca, Anastasi, Giuseppe Pio, Mazzon, Emanuela, Bramanti, Placido, Squadrito, Francesco, Altavilla, Domenica, Bitto, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671133/ https://www.ncbi.nlm.nih.gov/pubmed/36408237 http://dx.doi.org/10.3389/fphar.2022.1073726 |
Ejemplares similares
-
Activation of A2A Receptor by PDRN Reduces Neuronal Damage and Stimulates WNT/β-CATENIN Driven Neurogenesis in Spinal Cord Injury
por: Irrera, Natasha, et al.
Publicado: (2018) -
Pharmacological Activity and Clinical Use of PDRN
por: Squadrito, Francesco, et al.
Publicado: (2017) -
Corrigendum: Pharmacological activity and clinical use of PDRN
por: Squadrito, Francesco, et al.
Publicado: (2022) -
PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation
por: Irrera, Natasha, et al.
Publicado: (2020) -
Beneficial Effects of Polydeoxyribonucleotide (PDRN) in an In Vitro Model of Fuchs Endothelial Corneal Dystrophy
por: Ceravolo, Ida, et al.
Publicado: (2022)